Clinical Trials
14 trialsNCT05919264 2026-05-28
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Phase 1/2 Recruiting
NCT04281381 2026-05-15
Observing People With Desmoid-Type Fibromatosis
Memorial Sloan Kettering Cancer Center
Recruiting
NCT06268457 2026-05-14
Embodesmo
Istituto Ortopedico Rizzoli
Recruiting
NCT06224283 2026-05-12
Cryomics
Istituto Ortopedico Rizzoli
Recruiting
NCT07176689 2026-05-08
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 4 Recruiting
NCT02402244 2026-05-05
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Recruiting
NCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT07541430 2026-04-30
A Study in Adults With Desmoid Tumors
Elpiscience Biopharma, Ltd.
Phase 2 Recruiting
NCT07496242 2026-03-27
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT05111964 2026-02-04
SarcAblate
Oxford University Hospitals NHS Trust
Phase NA Recruiting
NCT06081400 2025-11-19
CRYODESMO-02
University Hospital, Strasbourg, France
Phase NA Recruiting
NCT06945887 2025-09-12
TAE-DESMO
Istituto Ortopedico Rizzoli
Recruiting
NCT05949099 2025-09-08
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Stanford University
Phase 2 Recruiting
NCT05091255 2025-08-01
Cryotherapy in the Treatment of Desmoid Tumors
Istituto Ortopedico Rizzoli
Phase NA Recruiting